{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:01:00Z","timestamp":1786122060308,"version":"build-2736575974"},"reference-count":18,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Pers. Med.","JPM"],"abstract":"<jats:p>Background: Non-group 1 pulmonary hypertension, also known as secondary pulmonary hypertension (SPH), is predominantly observed among females. However, there is a significant lack of data concerning factors associated with hospitalization among patients diagnosed with SPH. This study aims to provide clinicians with vital insights for the identification of high-risk groups and for the more effective management of contributory risk factors within the female population affected by SPH. Methods: Using the 2019 National Inpatient Sample, we identified female admissions with SPH (n = 648,190), accounting for 3.8% of the total 17,236,228 female admissions. An Artificial Neural Network (ANN) analysis was conducted to evaluate predictive factors. We randomly allocated 3,319,543 patients into training and testing datasets at a ratio of 70:30, comprising 2,323,696 (70%) for training and 995,847 (30%) for testing, to calibrate and validate the performance of the ANN algorithm. Model performance was assessed by comparing misclassification rates between training and testing sets and by the area under the receiver operating characteristic curve (AUC); only internal validation was performed. Results: Females hospitalized with SPH were generally of older age, with a median of 75 years compared to 58 years, and more frequently identified as White (67.7% versus 65.5%) or Black (20.5% versus 15.5%) relative to those without SPH. They also demonstrated a higher prevalence of most atherosclerotic cardiovascular disease (ASCVD) risk factors or their equivalents, including complicated hypertension (50.6% versus 17.8%), diabetes with chronic complications (30.6% versus 13.7%), and hyperlipidemia (50.8% versus 29.2%), as well as other comorbidities such as COPD (43.4% versus 20.2%) and CKD (43.3% versus 14.0%), and exhibited increased all-cause mortality (4.5% versus 1.8%) (p &lt; 0.001). Our ANN model achieved an AUC of 0.823, indicating good predictive capability. The rates of incorrect predictions were comparable in both the testing and training cohorts, at 3.8% each. The factors most strongly associated with a coded SPH diagnosis included age at admission, complicated hypertension, chronic kidney disease, chronic obstructive pulmonary disease, uncomplicated hypertension, prior VTE, race, arthropathies, and AIDS. Conclusions: Our ANN model identified demographic and comorbidity factors associated with a coded SPH diagnosis among hospitalized females, with good discrimination (AUC = 0.823). Because the model classifies the presence of an existing diagnosis rather than predicting future hospitalization, and was validated only internally, external and prospective validation is required before clinical application. Once validated, these factors could support individualized, sex-specific risk stratification for high-risk female populations, consistent with the goals of personalized medicine.<\/jats:p>","DOI":"10.3390\/jpm16080421","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:01:36Z","timestamp":1786089696000},"page":"421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Secondary Pulmonary Hypertension Among Hospitalized Females: An Artificial Neural Network Analysis of a National US Cohort"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4298-6459","authenticated-orcid":false,"given":"Adil Sarvar","family":"Mohammed","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Covenant HealthCare College of Medicine at Central Michigan University, Saginaw, MI 48602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Priyanka","family":"Mellacheruvu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Trinity Health-Nazareth Hospital, Philadelphia, PA 19152, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Prasanna","family":"Lekkala","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, UCHealth Parkview Medical Center, Pueblo, CO 81003, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvidha","family":"Manne","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St. Luke\u2019s Medical Center, Chesterfield, MO 63017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umera","family":"Yasmeen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mamata Medical College, Khamma 507002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iramunisa","family":"Begum","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shadan Institute of Medical Sciences, Hyderabad 500008, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5315-6426","authenticated-orcid":false,"given":"Rupak","family":"Desai","sequence":"additional","affiliation":[{"name":"Independent Researcher, Atlanta, GA 30033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Kambali","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, MyMichigan Medical Center, Saginaw, MI 48601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2200-8234","authenticated-orcid":false,"given":"Lakshmi Sai Meghana","family":"Kodali","sequence":"additional","affiliation":[{"name":"Department of Public Health and Health Sciences, University of Michigan-Flint, Flint, MI 48502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiny Teja","family":"Kolli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Phoebe Putney Memorial Hospital, Albany, GA 31701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaylika","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Health System, Wilkes-Barre, PA 18711, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kambali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, McLaren Bay Region, Bay City, MI 48708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.14-0527","article-title":"Pulmonary Hypertension Surveillance: United States, 2001 to 2010","volume":"146","author":"George","year":"2014","journal-title":"Chest"},{"key":"ref_3","unstructured":"(2026, May 27). HCUP-US Databases, Available online: https:\/\/hcup-us.ahrq.gov\/databases.jsp."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00281-024-01029-2","article-title":"The When, What, and Where of Naturally-Acquired Microchimerism","volume":"47","author":"Nelson","year":"2025","journal-title":"Semin. Immunopathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.201512-2511ED","article-title":"Estrogen: Friend or Foe in Pulmonary Hypertension?","volume":"193","author":"White","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.00027613","article-title":"Sex and Haemodynamics in Pulmonary Arterial Hypertension","volume":"43","author":"Ventetuolo","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/bph.16277","article-title":"Pulmonary Arterial Hypertension: Sex Matters","volume":"181","author":"Dignam","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sun, Y., Sangam, S., Guo, Q., Wang, J., Tang, H., Black, S.M., and Desai, A.A. (2021). Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.719058"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.sleep.2022.10.029","article-title":"The Comorbidity Burden and Disease Phenotype in Pre-Capillary Pulmonary Hypertension: The Contributing Role of Obstructive Sleep Apnea","volume":"101","author":"Duan","year":"2023","journal-title":"Sleep Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","article-title":"High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension","volume":"7","author":"Robbins","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/679705","article-title":"Impact of Diabetes in Patients with Pulmonary Hypertension","volume":"5","author":"Abernethy","year":"2015","journal-title":"Pulm. Circ."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.chest.2018.05.006","article-title":"Association Between BMI and Obesity with Survival in Pulmonary Arterial Hypertension","volume":"154","author":"Weatherald","year":"2018","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rodriguez-Arias, J.J., and Garc\u00eda-\u00c1lvarez, A. (2021). Sex Differences in Pulmonary Hypertension. Front. Aging, 2.","DOI":"10.3389\/fragi.2021.727558"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Wang, L., Zeng, H., Lv, Y., and Huang, Y. (2018). Epidemiology and Risk Factors in CKD Patients with Pulmonary Hypertension: A Retrospective Study. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-0866-9"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105864","DOI":"10.1155\/2014\/105864","article-title":"Trends in Pulmonary Hypertension Mortality and Morbidity","volume":"2014","author":"Mehari","year":"2014","journal-title":"Pulm. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e013034","DOI":"10.1161\/JAHA.119.013034","article-title":"Gender Differences in Risk Factors Associated with Pulmonary Artery Systolic Pressure, Heart Failure, and Mortality in Blacks: Jackson Heart Study","volume":"9","author":"Lakshmanan","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","unstructured":"(2026, May 27). Women Still Underrepresented in Clinical Research, Science and Medicine That Could Save Them from Their No. 1 Killer. Available online: https:\/\/newsroom.heart.org\/news\/women-still-underrepresented-in-clinical-research-science-and-medicine-that-could-save-them-from-their-no-1-killer."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cruz-Utrilla, A., Cristo-Ropero, M.J., Calder\u00f3n-Flores, M., Vel\u00e1zquez, M., L\u00f3pez-Gude, M.J., Revilla Ostolaza, Y., P\u00e9rez Vela, J.L., de la Cruz-B\u00e9rtolo, J., Bueno, H., and Arribas Ynsaurriaga, F. (2021). Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184251"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/8\/421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:19:34Z","timestamp":1786090774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/8\/421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jpm16080421"],"URL":"https:\/\/doi.org\/10.3390\/jpm16080421","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}